
Sofina backs Nuxe
Euronext Brussels-listed Sofina has acquired a 45% stake in family-owned, France-based cosmetics brand Nuxe.
The deal values Nuxe at around €500m; the business was marketed based on an EBITDA of €25m, according to French publication Capital Finance.
Founder Aliza Jabes has retained control over 55% of the business, a spokesperson for Sofina confirmed to Unquote. The stake was sold by the parents, brother and sister of Aliza Jabes.
Sofina will help the business to increase its international footprint and generate 60% of its revenues abroad in three to five years – up from 43% currently – Unquote has learned.
The GP, when acquiring minority stakes in companies valued between €250m-4.5bn, typically invests €75-300m, according to its website.
It became a minority investor in Belgium-based manufacturer of nappies and incontinence products Drylock Technologies last month and in France-based wine producer Maison Chapoutier in April this year.
Previous funding
Naxicap Partners bought a minority stake in Nuxe in 2008, according to Unquote Data. The company had an enterprise value of €40-50m at the time and the transaction saw LCL provide the debt package, consisting of an A and B tranche of senior debt as well as a mezzanine package.
Company
Nuxe was founded in 1957 and was taken over by current president Aliza Jabès in 1989, to give the company its current structure. Today the cosmetics brand is sold in pharmacies. It has its own research laboratory and factory in France, where it creates facial and body care products, based on botanical active ingredients.
Nuxe generated €275m in sales in 2018 and expects growth of around 9% this year, Unquote understands. The business is based in Boulogne-Billancourt and is currently active in 74 countries.
People
Nuxe – Aliza Jabes (founder).
Advisers
Company – Rothschild & Cie (corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater